St. Baldrick's Foundation

Celebrating 25 years of impact – St. Baldrick’s Foundation

St. Baldrick’s Foundation shared a post on X:

“As we celebrate 25 years of impact, we’re reminded of a key milestone from 2021: the 5-year survival rate for children with high-risk group 3 medulloblastoma increased from 54% to 73% by adding a chemotherapy drug during radiation.

Photo of honored kid Grace holding a sign saying When I Grow Up

Learn more.”

Source: St. Baldrick’s Foundation/X

cancer chemotherapy Children Cancer medulloblastoma OncoDaily Oncology St. Baldrick's Foundation